astx660
Showing 1 - 6 of 6
Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
Active, not recruiting
- Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
- ASTX660
-
Yamagata, JapanYamagata University Hospital
Feb 21, 2022
Advanced Cancer, Cervical Cancer, Triple Negative Breast Cancer Trial in Sutton (ASTX660, Pembrolizumab)
Recruiting
- Advanced Cancer
- +2 more
- ASTX660
- Pembrolizumab
-
Sutton, United KingdomRoyal Marden NHS Foundation Trust
May 25, 2022
Acute Myeloid Leukemia Trial in United States (ASTX660, ASTX727)
Active, not recruiting
- Acute Myeloid Leukemia
- ASTX660
- ASTX727
-
San Francisco, California
- +14 more
Jan 24, 2022
Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)
Active, not recruiting
- Solid Tumors
- Lymphoma
- ASTX660
-
Birmingham, Alabama
- +68 more
Nov 18, 2022
Healthy Volunteer Trial in Springfield (ASTX660, Midazolam, Itraconazole)
Completed
- Healthy Volunteer
- ASTX660
- +2 more
-
Springfield, MissouriQPS Bio-kinetic
Sep 14, 2020
Healthy Volunteer Trial in San Antonio (ASTX660)
Completed
- Healthy Volunteer
- ASTX660
-
San Antonio, TexasWorldwide Clinical Trials
Sep 14, 2020